Verrica Pharmaceuticals Inc (VRCA) Stock Analysis

Verrica Pharmaceuticals Inc (VRCA) is a publicly traded company in the HEALTHCARE sector. It trades at $5.79, carries a market capitalization of $101.36M. This page summarizes the public market data, fundamentals, and frequently asked questions for VRCA, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Verrica Pharmaceuticals Inc currently has a Bullish sentiment score of 0.35.

About Verrica Pharmaceuticals Inc

Verrica Pharmaceuticals Inc. is a specialized dermatological therapy company focused on the development and commercialization of innovative treatments for various skin conditions. Based in West Chester, Pennsylvania, Verrica aims to address significant unmet medical needs through its proprietary formulations and advanced delivery systems. The company is committed to improving patient outcomes by leveraging its expertise in dermatology to provide effective solutions for conditions such as comm...

GNG Research Analysis

GNG Research scores Verrica Pharmaceuticals Inc (VRCA) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for VRCA.

Frequently Asked Questions

Does VRCA pay dividends?

Verrica Pharmaceuticals Inc (VRCA) does not currently pay a regular dividend.

What is VRCA's market cap?

Verrica Pharmaceuticals Inc (VRCA) has a market capitalization of $101.36M with a current stock price of $5.79.